The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Senotherapy preserves resilience in aging Mikawa 2024 Geriatrics & Gerontology International Wiley Online Library Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri senolytic 2024 Development of a novel senolytic by precise disruption of FOXO4-p53 complex